Table of Content

1 Market Overview of Cancer Diagnostics
1.1 Cancer Diagnostics Market Overview
1.1.1 Cancer Diagnostics Product Scope
1.1.2 Cancer Diagnostics Market Status and Outlook
1.2 Global Cancer Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Cancer Diagnostics Market Size by Region (2018-2033)
1.4 Global Cancer Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Cancer Diagnostics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Cancer Diagnostics Market Size (2018-2033)
1.6.1 North America Cancer Diagnostics Market Size (2018-2033)
1.6.2 Europe Cancer Diagnostics Market Size (2018-2033)
1.6.3 Asia-Pacific Cancer Diagnostics Market Size (2018-2033)
1.6.4 Latin America Cancer Diagnostics Market Size (2018-2033)
1.6.5 Middle East & Africa Cancer Diagnostics Market Size (2018-2033)
2 Cancer Diagnostics Market by Type
2.1 Introduction
2.1.1 Platform-based
2.1.2 Instrument-based
2.2 Global Cancer Diagnostics Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Cancer Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Diagnostics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Cancer Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Cancer Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Cancer Diagnostics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Cancer Diagnostics Revenue Breakdown by Type (2018-2033)
3 Cancer Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Breast Cancer
3.1.2 Lung Cancer
3.1.3 Colorectal Cancer
3.1.4 Others
3.2 Global Cancer Diagnostics Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Cancer Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Diagnostics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Cancer Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Cancer Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Cancer Diagnostics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Cancer Diagnostics Revenue Breakdown by Application (2018-2033)
4 Cancer Diagnostics Competition Analysis by Players
4.1 Global Cancer Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Diagnostics as of 2022)
4.3 Date of Key Players Enter into Cancer Diagnostics Market
4.4 Global Top Players Cancer Diagnostics Headquarters and Area Served
4.5 Key Players Cancer Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Becton, Dickinson and Company
5.1.1 Becton, Dickinson and Company Profile
5.1.2 Becton, Dickinson and Company Main Business
5.1.3 Becton, Dickinson and Company Cancer Diagnostics Products, Services and Solutions
5.1.4 Becton, Dickinson and Company Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Becton, Dickinson and Company Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Cancer Diagnostics Products, Services and Solutions
5.2.4 GE Healthcare Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Cancer Diagnostics Products, Services and Solutions
5.3.4 Abbott Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Cancer Diagnostics Products, Services and Solutions
5.4.4 Roche Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Cancer Diagnostics Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Agilent Technologies
5.6.1 Agilent Technologies Profile
5.6.2 Agilent Technologies Main Business
5.6.3 Agilent Technologies Cancer Diagnostics Products, Services and Solutions
5.6.4 Agilent Technologies Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies Recent Developments
5.7 Illumina
5.7.1 Illumina Profile
5.7.2 Illumina Main Business
5.7.3 Illumina Cancer Diagnostics Products, Services and Solutions
5.7.4 Illumina Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Illumina Recent Developments
5.8 Siemens Healthcare
5.8.1 Siemens Healthcare Profile
5.8.2 Siemens Healthcare Main Business
5.8.3 Siemens Healthcare Cancer Diagnostics Products, Services and Solutions
5.8.4 Siemens Healthcare Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthcare Recent Developments
5.9 C.R. Bard
5.9.1 C.R. Bard Profile
5.9.2 C.R. Bard Main Business
5.9.3 C.R. Bard Cancer Diagnostics Products, Services and Solutions
5.9.4 C.R. Bard Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 C.R. Bard Recent Developments
6 North America
6.1 North America Cancer Diagnostics Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Diagnostics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Diagnostics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Diagnostics Market Dynamics
11.1 Cancer Diagnostics Industry Trends
11.2 Cancer Diagnostics Market Drivers
11.3 Cancer Diagnostics Market Challenges
11.4 Cancer Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Cancer Diagnostics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Cancer Diagnostics Market Size Share by Region (2018-2023)
Table 4. Global Cancer Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Cancer Diagnostics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Cancer Diagnostics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global Cancer Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Cancer Diagnostics Revenue Market Share by Type (2024-2033)
Table 11. North America Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Cancer Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Cancer Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Cancer Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Cancer Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Cancer Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Cancer Diagnostics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Cancer Diagnostics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Cancer Diagnostics Revenue Market Share by Application (2018-2023)
Table 24. Global Cancer Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Cancer Diagnostics Revenue Market Share by Application (2024-2033)
Table 26. North America Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Cancer Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Cancer Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Cancer Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Cancer Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Cancer Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Cancer Diagnostics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Cancer Diagnostics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Cancer Diagnostics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Diagnostics as of 2022)
Table 39. Date of Key Players Enter into Cancer Diagnostics Market
Table 40. Global Cancer Diagnostics Key Players Headquarters and Area Served
Table 41. Cancer Diagnostics Product Solution and Service
Table 42. Global Cancer Diagnostics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Becton, Dickinson and Company Basic Information List
Table 45. Becton, Dickinson and Company Description and Business Overview
Table 46. Becton, Dickinson and Company Cancer Diagnostics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cancer Diagnostics Business of Becton, Dickinson and Company (2018-2023)
Table 48. Becton, Dickinson and Company Recent Developments
Table 49. GE Healthcare Basic Information List
Table 50. GE Healthcare Description and Business Overview
Table 51. GE Healthcare Cancer Diagnostics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cancer Diagnostics Business of GE Healthcare (2018-2023)
Table 53. GE Healthcare Recent Developments
Table 54. Abbott Basic Information List
Table 55. Abbott Description and Business Overview
Table 56. Abbott Cancer Diagnostics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cancer Diagnostics Business of Abbott (2018-2023)
Table 58. Abbott Recent Developments
Table 59. Roche Basic Information List
Table 60. Roche Description and Business Overview
Table 61. Roche Cancer Diagnostics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cancer Diagnostics Business of Roche (2018-2023)
Table 63. Roche Recent Developments
Table 64. Thermo Fisher Scientific Basic Information List
Table 65. Thermo Fisher Scientific Description and Business Overview
Table 66. Thermo Fisher Scientific Cancer Diagnostics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cancer Diagnostics Business of Thermo Fisher Scientific (2018-2023)
Table 68. Thermo Fisher Scientific Recent Developments
Table 69. Agilent Technologies Basic Information List
Table 70. Agilent Technologies Description and Business Overview
Table 71. Agilent Technologies Cancer Diagnostics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cancer Diagnostics Business of Agilent Technologies (2018-2023)
Table 73. Agilent Technologies Recent Developments
Table 74. Illumina Basic Information List
Table 75. Illumina Description and Business Overview
Table 76. Illumina Cancer Diagnostics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Cancer Diagnostics Business of Illumina (2018-2023)
Table 78. Illumina Recent Developments
Table 79. Siemens Healthcare Basic Information List
Table 80. Siemens Healthcare Description and Business Overview
Table 81. Siemens Healthcare Cancer Diagnostics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Cancer Diagnostics Business of Siemens Healthcare (2018-2023)
Table 83. Siemens Healthcare Recent Developments
Table 84. C.R. Bard Basic Information List
Table 85. C.R. Bard Description and Business Overview
Table 86. C.R. Bard Cancer Diagnostics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Cancer Diagnostics Business of C.R. Bard (2018-2023)
Table 88. C.R. Bard Recent Developments
Table 89. North America Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 90. North America Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 91. Europe Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 92. Europe Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 93. Asia-Pacific Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 94. Asia-Pacific Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 95. Asia-Pacific Cancer Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 96. Asia-Pacific Cancer Diagnostics Market Share by Region (2018-2023)
Table 97. Asia-Pacific Cancer Diagnostics Market Share by Region (2024-2033)
Table 98. Latin America Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Latin America Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 100. Latin America Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 101. Middle East & Africa Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 102. Middle East & Africa Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 103. Middle East & Africa Cancer Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 104. Cancer Diagnostics Market Trends
Table 105. Cancer Diagnostics Market Drivers
Table 106. Cancer Diagnostics Market Challenges
Table 107. Cancer Diagnostics Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Diagnostics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Cancer Diagnostics Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Cancer Diagnostics Market Share by Regions: 2022 VS 2033
Figure 4. Global Cancer Diagnostics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Cancer Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Cancer Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Cancer Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Cancer Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Cancer Diagnostics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Platform-based
Figure 11. Global Platform-based Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Instrument-based
Figure 13. Global Instrument-based Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Cancer Diagnostics Market Size Share by Type: 2022 & 2033
Figure 15. North America Cancer Diagnostics Revenue Market Share by Type (2018-2033)
Figure 16. Europe Cancer Diagnostics Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Cancer Diagnostics Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Cancer Diagnostics Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Cancer Diagnostics Revenue Market Share by Type (2018-2033)
Figure 20. Breast Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Lung Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Global Cancer Diagnostics Market Size Share by Application: 2022 & 2033
Figure 25. North America Cancer Diagnostics Revenue Market Share by Application (2018-2033)
Figure 26. Europe Cancer Diagnostics Revenue Market Share by Application (2018-2033)
Figure 27. Asia-Pacific Cancer Diagnostics Revenue Market Share by Application (2018-2033)
Figure 28. Latin America Cancer Diagnostics Revenue Market Share by Application (2018-2033)
Figure 29. Middle East and Africa Cancer Diagnostics Revenue Market Share by Application (2018-2033)
Figure 30. Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Cancer Diagnostics Market Share in 2022
Figure 32. North America Cancer Diagnostics Market Share by Country (2018-2033)
Figure 33. U.S. Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 34. Canada Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 35. Germany Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 36. France Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 37. U.K. Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 38. Italy Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 39. Russia Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 40. Nordic Countries Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 41. Asia-Pacific Cancer Diagnostics Market Share by Region (2018-2033)
Figure 42. China Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 43. Japan Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 44. South Korea Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 46. India Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 47. Australia Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 48. Latin America Cancer Diagnostics Market Share by Country (2018-2033)
Figure 49. Mexico Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 50. Brazil Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Cancer Diagnostics Market Share by Country (2018-2033)
Figure 52. Turkey Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 54. UAE Cancer Diagnostics Market Size (2018-2033) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report